⌂ /Comparison Service /

Share Copy the link Share in Facebook Share in Twitter Share in Telegram Share in ВКонтакте

Comparison results

 

Results: Differences General	✘Bleeding from the bladder	✘Autoimmune oophoritis
Related research	Analogs	Analogs
Register, to see more distinctive signs of diseases and studies 81%(1) 81%(3) Autoimmune markers — 100%(2) General urine test 88%(2) — Blood biochemistry — 72%(3) Sex hormones — 41%(3) Ultrasound of the organ — 23%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies	100%	—
Register, to see more distinctive signs of diseases and studies	—	100%
frequent stools	82%	—
inflammation of the ovaries	—	57%
can't hold urine	73%	—
primary infertility	—	53%
urinary incontinence	70%	—
resistant ovary syndrome	—	52%
bleeding from the bladder	43%	—
infertility female	—	49%
bleeding	38%	—
ovarian dysfunction	—	48%
gonorrheal vulvovaginitis	36%	—
uterine appendages are increase	—	46%
gonorrhea in the anamnesis	34%	—
appendicular-genital syndrome	—	45%
cold knees	32%	—
ovarian insufficiency	—	45%
consequences of acute respiratory	31%	—
appendages of the uterus	—	45%
frequent colds in childhood	30%	—
menstruation disorder	—	45%
acute urethritis	30%	—
chronic oophoritis	—	43%
cold legs	27%	—
female pelvic organs	—	41%
red urine	26%	—
pregnancy	—	41%
distracted	26%	—
ovarian tumors	—	40%
gout	26%	—
uterine infertility	—	39%
acute blood loss	25%	—
adhesions in the pelvis	—	38%
pain in the bladder	24%	—
salpingitis	—	37%
rheumatism	23%	—
adnexitis	—	37%
bruise	22%	—
stopped menstruation	—	36%
inflammation of the kidneys	21%	—
primary and secondary amenorrhea	—	36%
patient is motionless	18%	—
menstruation irregular	—	35%
acute pain	17%	—
chronic endocervicitis	—	34%
kidney diseases	17%	—
tubal infertility	—	34%
blood diseases	16%	—
clamidiosis in women	—	33%
drug disease	—	33%
secondary amenorrhea	—	33%
autoimmune oophoritis	—	33%
gonorrhea in women	—	33%
endocrine infertility	—	33%
neoplasms in small pelvis	—	32%
ovulatory syndrome	—	32%
secondary infertility	—	32%
shows genitals	—	31%
trichomoniasis	—	31%
trichomoniasis in women	—	31%
ovarian endometriosis	—	31%
urogenital clamidiosis	—	30%
progesterone deficiency	—	30%
necrosis	—	30%
benign ovarian tumors	—	29%
impaired uterine function	—	29%
monthly short	—	28%
primary amenorrhea	—	28%
monthly prolonged	—	28%
intra-phase infections	21%	48%
follicular cyst	—	27%
ovarian cancer	—	27%
gynecological operations in the anamnesis	—	26%
lowered	—	26%
clamidiosis	—	26%
ovarian hypofunction	—	26%
germinogenic tumors	—	25%
endometriosis	—	25%
lymphocytosis	—	25%
endometritis	—	24%
lack of menstruation	—	24%
lower abdominal pain	—	23%
polycystic	—	23%
consequences of taking medications	—	22%
uterine tumor	—	22%
cystic fibrosis	—	22%
the consequences of taking antibiotic therapy	—	22%
belly enlargement	—	21%
abortions	—	21%
inflammation	15%	35%
heredity predisposition	—	20%
remission	—	20%
caution	—	20%
consequences of childbirth	—	19%
benign neoplasms	—	19%
hormonal disorders	—	18%
abdominal pain	—	18%
subacute condition	—	18%
immunodeficiency	—	18%
increased	15%	33%
surgical infections	—	18%
presses	—	18%
oncology	15%	31%
onset of illness	—	16%
history of surgery	—	15%
vulvovaginitis	21%	31%
vulva infections	21%	31%
patient's condition	15%	22%
consequences of infection	16%	17%
endocervicitis	25%	25%
gonorrhea	26%	26%
urethritis	26%	26%
cancer	17%	17%
gonorrheal urethritis	31%	31%

Instructions

Video

Introduce new diseases through 🔍 Search and input on the top panel using Compare The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease. The list changes dynamically depending on the data of the current visit in the selection of therapy . Click on the percentageto see the suggestions from the original source. By using the service, you agree to user agreement. Kiberis services do not replace a doctor! ▶ Look at ▶Youtube